Loading company…
Suzhou Biosynthetica uses synthetic biology to produce nucleotide-related materials and pharmaceutical ingredients.
Founded in 2014 and based in Suzhou, China, Suzhou Biosynthetica develops nucleotide-related raw materials and active pharmaceutical ingredients using synthetic biology. Its products include L-Histidine, L-Carnosine and other amino acid derivatives for pharmaceutical, nutrition and food applications. The company sells to businesses in pharmaceutical, supplement and food markets. In January 2026, it raised CNY 100 million in Series A funding led by Hunan Xingxiang Investment Holding Group, with participation from Zero2IPO Ventures and Zhangjiagang Industrial Capital Center.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in